Trials / Unknown
UnknownNCT02961296
Helicobacter Pylori Antibiotic Susceptibility Testing of Korea
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- All
- Age
- 19 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to make nationwide registry for antimicrobial resistance of Helicobacter pylori using single method with agar dilution in Korea.
Detailed description
Backgrounds: The success rate of Helicobacter pylori eradication in Korea is not sufficient in recent days. The main cause of eradication failure is known as antimicrobial resistance and previous studies showed that resistant rates were different according to the regions in Korea. However, until now, there are not enough studies about the nationwide results for antimicrobial resistance and previous reports used various methods for the resistant test. Theories and Plans: The nationwide resistant registry of Helicobacter pylori using standardized single method, agar dilution test, can be useful for the development of new eradication methods to make eradication rate higher. Moreover, the higher rate of Helicobacter pylori eradication can reduce the chance of gastric cancer and also can reduce the medical expenses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention will be needed. |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-12-01
- Completion
- 2018-12-01
- First posted
- 2016-11-10
- Last updated
- 2016-11-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02961296. Inclusion in this directory is not an endorsement.